Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Immunotherapy Approaches for Treating Prostate Cancer
Lingbin Meng, Yuanquan Yang, Amir Mortazavi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14347-14347
Open Access | Times Cited: 13

Showing 13 citing articles:

Challenges and opportunities in single-domain antibody-based tumor immunotherapy
Xiaozhi Xi, Guo Shu-hua, Yuchao Gu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189284-189284
Closed Access
Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches
Adam Khorasanchi, Feng Hong, Yuanquan Yang, et al.
Cancer Drug Resistance (2025)
Open Access
The application of emerging immunotherapy in the treatment of prostate cancer: progress, dilemma and promise
Jizhong Che, Yuanyuan Liu, Yangyang Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Antrodia cinnamomea Formula Suppresses Prostate Cancer Progression via Immune Modulation and PD-1/PD-L1 Pathway Inhibition
Ming-Yen Tsai, Chung-Kuang Lu, Li‐Hsin Shu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2684-2684
Open Access
YTHDF1/RNF7/p27 axis promotes prostate cancer progression
Yulin Shi, Baiyang Liu, Yong Zhang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer
Wei Li, Feng Guo, Ruijiang Zeng, et al.
Cancer Research (2024) Vol. 84, Iss. 16, pp. 2588-2606
Closed Access | Times Cited: 3
Treatment-induced neuroendocrine prostate cancer and de novo neuroendocrine prostate cancer: Identification, prognosis and survival, genetic and epigenetic factors
Mohamed Wishahi
World Journal of Clinical Cases (2024) Vol. 12, Iss. 13, pp. 2143-2146
Open Access | Times Cited: 2
PSMA-based therapeutics for prostate cancer
Panagiotis Velissarios Stamatakos, Charalampos Fragkoulis, Aggeliki Leventi, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 10, pp. 1405-1419
Closed Access | Times Cited: 2
Developmental Therapeutics in Metastatic Prostate Cancer: New Targets and New Strategies
Jingsong Zhang, Juskaran Chadha
Cancers (2024) Vol. 16, Iss. 17, pp. 3098-3098
Open Access | Times Cited: 2
Special Issue: “Novel Researches and Perspectives on Prostate Cancer”
Giovanni Luca Beretta
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2054-2054
Open Access
New approaches and prospects of immunotherapy and gene therapy for prostate cancer
Roshni Bibi, Koustav Sarkar
Journal of Translational Genetics and Genomics (2024) Vol. 8, Iss. 2, pp. 119-161
Open Access
Application and new findings of scRNA-seq and ST-seq in prostate cancer
Li Zhuang, Zhengnan Li, Yuanyuan Luo, et al.
Cell Regeneration (2024) Vol. 13, Iss. 1
Open Access
Comprehensive gene set enrichment and variation analyses identify SUV39H1 as a potential prognostic biomarker for glioblastoma immunorelevance
Jixuan Liu, Qian Luo, Haoran Zhao, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 4161-4176
Open Access
Page 1

Scroll to top